Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes

Clinical and Experimental Immunology

Volumn 105, Issue 2, 1996, Pages 330-337

  Sai P ^a   Rivereau, A S ^a   Granier, C ^b   Haertle T H ^c   Martignat, L ^a  

^a UNIVERSITÉ DE NANTES   (France)

^b UNIV MONTPELLIER   (France)

^c CEMAGREF   (France)

Author keywords

Diabetes; GAD65; NOD mice; Prevention; Synthetic peptides

Indexed keywords

CYCLOPHOSPHAMIDE; FREUND ADJUVANT; GLUTAMATE DECARBOXYLASE; INTERLEUKIN 10; INTERLEUKIN 4; SYNTHETIC PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HELPER CELL; IMMUNIZATION; INSULIN DEPENDENT DIABETES MELLITUS; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0030018536     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-751.x     Document Type: Article

References (32)

1. Bowman MA, Leiter EH, Atkinson MA. Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease. Immunol Today 1994; 15:115-20.
2. Castano L, Eisenbarth GS. Type 1 diabetes: a chronic autoimmune disease of man, mouse and rat. Annu Rev Immunol 1990; 8:647-79.
3. Elias D, Reshef T, Birk OS, van der Zee R, Walker MD, Cohen IR. Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65 kDa heat shock protein. Proc Natl Acad Sci USA 1991; 88:3088-91.
4. Baekkeskov S, Aanstoot HK, Christgau S et al. Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347:151-6.
5. Baekkeskov S, Landin M, Kristensen JK et al. Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest 1987; 79:926-34.
6. Atkinson MA, Maclaren NK. Autoantibodies in non-obesediabetic mice immunoprecipitat; 64,000 Mr islet antigen. Diabetes 1988; 37:1587-90.
7. Kaufman DL, Clare-Satzler M, Tian J et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993; 366:69-72.
8. Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993; 366:72-75.
9. Bieg S, Seissler J, Herberg L, Northemann W, Scherbaum WA. GAD (65) is recognized by T-cells, but not by antibodies from NOD-mice. Autoimmunity 1994; 17:189-94.
10. Elliot JF, Qin HY, Bhatti S, Smith DK, Kumari Singh R, Dillon T, Lauzon J, Singh B. Immunization with the larger isoform of mouse glutamic acid decarboxylase (GAD67) prevents autoimmune diabetes in NOD mice. Diabetes 1994; 43:1494-9.
11. Gerling IC, Atkinson MA, Leiter EH. The thymus as a site for evaluating the potency of candidate β cell autoantigens in NOD mice. J Autoimmun 1994; 7:851-8.
12. Petersen JS, Karlsen AE, Markholst H, Worsaae A, Dyrberg T, Michelsen B. Neonatal tolerization with glutamic acid decarboxylase but not with serum albumin delays the onset of diabetes in NOD mice. Diabetes 1994; 44:1478-84.
13. Pleau JM, Fernandez-Saravia F, Esling A, Homo-Delarche F, Dardenne M. Prevention of autoimmune diabetes in non-obese diabetic female mice by treatment with recombinant glutamic acid decarboxylase (GAD 65). Clin Immunol lmmunopathol 1995; 76:90-95.
14. Tisch R, Yang XD, Liblau R, McDevitt HO. Administering glutamic acid decarboxylase to NOD mice prevents diabetes. J Autoimmun 1994; 7:845-50.
15. Harada M, Makino S. Promotion of spontaneous diabetes in nonobese diabetes-prone mice by cyclophosphamide. Diabetologia 1984; 27:604-6.
16. Yasunami R, Bach JF. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur J Immunol 1988; 18:481-4.
17. Wicker LS, Miller BJ, Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 1986; 35:855-60.
18. + cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 1995; 34:34-38.
19. Platica O, Janeczko R, Quadros EV, Regec A, Romain R, Rothenberg SP. The cDNA sequence and the deduced amino acid sequence of human transcobalamin II show homology with rat intrinsic factor and human transcobalamin I. J Biol Chem 1991; 266:7860 3.
20. Martignat L, El Mansour A, Audrain M, Julien JF, Saï P. NOD mice express high amounts of pancreatic glutamic acid decarboxylase and of antigens for cytoplasmic islet cell antibodies. J Autoimmun 1995; 8:465-82.
21. Saï P, Senecat O, Martignat L, Gouin E. Enhancement of diabetes in NOD mice by neonatal injections of cyclosporin A. Clin Exp Immunol 1994; 97:138-43.
22. Senecat O, Martignat L, Elmansour A, Audrain M, Julien JF, Saï P. Diabetes enhancement of diabetes and increased islet antigen expression in NOD mice following neonatal injections of glucose and arginine. Metab Clin Exp 1994; 43:1-10.
23. Abrams JS, Roncarolo MG, Yssel H, Anderson U, Gleich GJ, Silver JE. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples, Immunol Rev 1992; 127:5-21.
24. Velloso LA, Kämpe O, Haliberg A, Christmanson L, Betsholtz C, Karlsson FA. Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression. J Clin Invest 1993; 91:2084-90.
25. Kim J, Richter W, Aanstoot HJ, Shi Y, Fu Q, Rajotte R, Warnock G, Baekkeskov S. Differential expression of GAD65 and GAD67 in human, rat. and mouse pancreatic islets. Diabetes 1993; 42:1799-808.
26. Velloso L, Kämpe O, Izirik DL, Hallberg A, Anderson A, Karlsson FA. Human autoantibodies react with glutamic acid decarboxylase antigens in human and in rat but not in mouse islets. Diabetologia 1993; 36:39-46.
27. Campbell IL, Kay TWH, Oxbrow L, Harrison LC, Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 1991; 87:739-42.
28. Rothe H, Schade U, Kleemann R, Bosse G, Hibino T, Martin S, Kolb H. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not of interleukin-4. Diabetologia 1994; 37:1154-8.
29. Chen SL, Whiteley PJ, Freed DC, Rothbard JB, Peterson LB, Wicker LS. Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide. J Autoimmun 1994; 7:635-41.
30. Shehadeh NN, La Rosa F, Lafferty KJ, Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J Autoimmun 1993; 6:291-300.
31. Rapoport MJ, Jaramillo A, Zipris D et al. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in the nonobese diabetic mouse. J Exp Med 1993; 178:87-99.
32. Reich EP, Geissberger D, Mukku P, Dunsavage M, Stewart M, Deshpande S, Kindsvogel W, Nag B. Interaction of GAD65 peptide analogs to NOD MHC Class II and T cell receptor. Autoimmunity 1995 21: A197 (Abstr.).